| 08/03/22 | 07:03:48 | 8 Mar 2022 | | Publication: Nanopore IDs >50 genetic diseases | RNS |
| 01/03/22 | 17:00:02 | 1 Mar 2022 | | Issue of Equity and Total Voting Rights | RNS |
| 24/02/22 | 07:00:12 | 24 Feb 2022 | | Notice of Results | RNS |
| 11/02/22 | 17:30:01 | 11 Feb 2022 | | Share Incentive Plan - Director/PDMR Shareholding | RNS |
| 01/02/22 | 17:00:07 | 1 Feb 2022 | | Issue of Equity and Total Voting Rights | RNS |
| 24/01/22 | 15:00:01 | 24 Jan 2022 | | Appointment of Senior Independent Director | RNS |
| 18/01/22 | 13:00:05 | 18 Jan 2022 | | Holding(s) in Company | RNS |
| 13/01/22 | 07:00:06 | 13 Jan 2022 | | Fastest human genome sequence uses Oxford Nanopore | RNS |
| 11/01/22 | 18:00:02 | 11 Jan 2022 | | Share Incentive Plan - Director/PDMR Shareholding | RNS |
| 07/01/22 | 12:00:02 | 7 Jan 2022 | | Update to FY21 revenue guidance | RNS |
| 07/01/22 | 07:00:07 | 7 Jan 2022 | | Company to present at JP Morgan Healthcare conf | RNS |
| 04/01/22 | 18:30:05 | 4 Jan 2022 | | Issue of Equity and Total Voting Rights | RNS |
| 20/12/21 | 17:00:02 | 20 Dec 2021 | | Holding(s) in Company | RNS |
| 13/12/21 | 18:15:08 | 13 Dec 2021 | | Share Incentive Plan - Director/PDMR Shareholding | RNS |
| 02/12/21 | 07:00:07 | 2 Dec 2021 | | Oxford Nanopore announces technology updates | RNS |
| 01/12/21 | 07:00:09 | 1 Dec 2021 | | Issue of Equity and Total Voting Rights | RNS |
| 09/11/21 | 07:03:40 | 9 Nov 2021 | | Update to revenue guidance | RNS |
| 03/11/21 | 18:00:02 | 3 Nov 2021 | | Holding(s) in Company | RNS |
| 01/11/21 | 18:30:02 | 1 Nov 2021 | | PDMR Notification (ESPP) and Director Declaration | RNS |
| 01/11/21 | 07:00:11 | 1 Nov 2021 | | Issue of Equity and Total Voting Rights | RNS |
| 14/10/21 | 17:33:00 | 14 Oct 2021 | | Upgrade to full-year revenue guidance | RNS |
| 13/10/21 | 18:20:00 | 13 Oct 2021 | | Share Incentive Plan, Director/PDMR Transactions | RNS |
| 08/10/21 | 12:00:01 | 8 Oct 2021 | | Exercise of Over-allotment Option | RNS |
| 08/10/21 | 07:00:01 | 8 Oct 2021 | | Notification of Transactions of Director/PDMR | RNS |
| 08/10/21 | 07:00:01 | 8 Oct 2021 | | Total Voting Rights | RNS |
| 07/10/21 | 18:00:00 | 7 Oct 2021 | | Holding(s) in Company | RNS |
| 07/10/21 | 18:00:00 | 7 Oct 2021 | | Holding(s) in Company | RNS |
| 07/10/21 | 18:00:00 | 7 Oct 2021 | | Holding(s) in Company | RNS |
| 05/10/21 | 15:45:08 | 5 Oct 2021 | | Total Voting Rights | RNS |
| 05/10/21 | 15:45:08 | 5 Oct 2021 | | Block Listing Application/Directorate Change | RNS |
| 05/10/21 | 07:00:05 | 5 Oct 2021 | | Admission to Trading on the London Stock Exchange | RNS |
| 04/10/21 | 17:51:19 | 4 Oct 2021 | | Exercise of Over-allotment Option | RNS |
| 30/09/21 | 13:13:05 | 30 Sept 2021 | | Approval and Publication of Prospectus | RNS |
| 30/09/21 | 07:00:13 | 30 Sept 2021 | | Announcement of Offer Price | RNS |
| 16/09/21 | 07:00:05 | 16 Sept 2021 | | Intention to Float | RNS |
| 10/09/21 | 14:40:23 | 10 Sept 2021 | | Publication of Registration Document | RNS |
| 09/09/21 | 11:30:08 | 9 Sept 2021 | | Expected Intention to Float | RNS |
